What is Drug Conjugate (ADC)?

Antibody-Drug Conjugate

Quick Answer

A Drug Conjugate (ADC) is a targeted cancer therapy that combines a drug with an antibody. This combination allows the drug to specifically attack cancer cells while minimizing damage to healthy cells.

Overview

A Drug Conjugate (ADC) is a type of medication used primarily in cancer treatment. It consists of an antibody linked to a drug that can kill cancer cells. The antibody specifically recognizes and binds to cancer cells, delivering the drug directly to them while sparing normal cells, which helps reduce side effects commonly associated with traditional chemotherapy. The way ADCs work is by using the antibody to latch onto specific proteins found on the surface of cancer cells. Once the ADC binds to these cells, it is taken inside, where the attached drug is released to destroy the cancer cell from within. This targeted approach can improve the effectiveness of the treatment and provide a more precise way to combat cancer compared to conventional methods. One well-known example of an ADC is trastuzumab emtansine, which is used to treat certain types of breast cancer. This therapy targets the HER2 protein, which is overexpressed in some breast cancers. By delivering the cytotoxic drug directly to the cancer cells, trastuzumab emtansine can help shrink tumors and improve patient outcomes, highlighting the importance of ADCs in modern pharmacology.

Frequently Asked Questions

What types of cancers can Drug Conjugates be used for?

ADCs are primarily used for various types of cancers, especially those that express specific proteins targeted by the antibody. Common cancers treated with ADCs include breast cancer, lymphoma, and leukemia.

Are there side effects associated with Drug Conjugates?

Yes, while ADCs are designed to minimize damage to healthy cells, they can still cause side effects. These may include fatigue, nausea, and potential allergic reactions, but they are often less severe than those from traditional chemotherapy.

How do researchers develop new Drug Conjugates?

Researchers develop new ADCs by identifying antibodies that can target specific cancer cell markers and pairing them with potent drugs. This process involves extensive testing to ensure that the ADC effectively delivers the drug to cancer cells while minimizing harm to normal cells.